Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-13 · accession 0001593968-23-000317 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-14 | 2023-02-13 | ALLO | Bhavnagri Veer | GC | S - Sale | $6.85 | -3,000 | 577.7K | -0.5% | -$20.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | S | D | 3,000 | $6.85 | 577,677 | D | — | — | (F1) 1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022. |